SCHEMBL7204065

SCHEMBL7204065

CCc1ccc(Cl)c(NC#N)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.39
CYP2A6 P11509 2/20 0.38
TRPA1 O75762 1/20 0.34
SLC6A2 P23975 2/20 0.33
SLC6A4 P31645 2/20 0.33
SLC6A3 Q01959 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP1A2 P05177 1/20 0.33
SIGMAR1 Q99720 5/20 0.33
ACACB O00763 1/20 0.32
ALDH1A1 P00352 2/20 0.31
MAPT P10636 2/20 0.31
HPGD P15428 2/20 0.31
KDM4E B2RXH2 2/20 0.31
HSD17B10 Q99714 2/20 0.31
LMNA P02545 2/20 0.31
MEN1 O00255 1/20 0.31
NPC1 O15118 1/20 0.31
TP53 P04637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13754322 0.77 GAA (0.43) GAACYP2A6TRPA1SLC6A2SLC6A4
SCHEMBL21696318 0.76 GAA (0.42) GAACYP2A6TRPA1SLC6A2SLC6A4
SCHEMBL7202279 0.75 MEN1 (0.46) CYP3A4ALDH1A1MAPTHPGDHSD17B10
SCHEMBL11664814 0.73 ALDH1A1 (0.32) ALDH1A1MAPTKDM4EHSD17B10MEN1
SCHEMBL12188756 0.72 CYP2A6 (0.47) CYP2A6TRPA1CYP3A4CYP2D6CYP1A2
SCHEMBL6847030 0.71 KMT2A (0.38) GAASLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL6847349 0.71 TDP1 (0.48) GAASLC6A4CYP3A4CYP2D6CYP1A2
SCHEMBL996051 0.71
SCHEMBL11665860 0.70 CYP3A4 (0.44) GAASLC6A2SLC6A4SLC6A3CYP3A4
SCHEMBL14468484 0.70 DRD2 (0.48) GAAALDH1A1MAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1188121-C Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 2005-02-09 CN disclosed
EP-0705100-B1 THERAPEUTIC SUBSTITUTED GUANIDINES CENES LTD (GB) 2003-07-30 EP disclosed
US-6156741-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-12-05 US disclosed
US-6153604-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-11-28 US disclosed
US-6147063-A NEUROTOXICITY CAMBRIDGE NEUROSCIENCE, INC. (US) 2000-11-14 US disclosed
CN-1126434-A Therapeutic substituted guanidines CAMBRIDGE NEUROSCIENCE INC (US) 1996-07-10 CN disclosed
EP-0705100-A4 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE INC (US) 1996-05-29 EP disclosed
EP-0705100-A1 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1996-04-10 EP disclosed
WO-1994027591-A1 THERAPEUTIC SUBSTITUTED GUANIDINES CAMBRIDGE NEUROSCIENCE, INC. (US) 1994-12-08 WO disclosed